Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for Paclitaxel Toxicity in Breast Cancer
NCT06570811Phase 2Completed
- Sponsor
- Damanhour University
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of coenzyme q10 in chemotherapy-induced toxicity (2 arms), sponsored by Damanhour University. Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events at 3 months. Started Aug 2024; status: completed.
02
Drugs
coenzyme q10
03
Conditions
chemotherapy-induced toxicity
Beyond the preview
Go deeper on NCT06570811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570811.